Skip to main content
Premium Trial:

Request an Annual Quote

Enzo Gets NY State OK to Sell GeneNews Test

NEW YORK (GenomeWeb News) – The Enzo Clinical Labs division of Enzo Biochem has received approval from the New York State Department of Health to market GeneNews' ColonSentry test to residents of the state.

ColonSentry is a gene expression assay for assessing a patient's risk for colorectal cancer. Enzo holds the exclusive rights to market the test in New York and New Jersey under an agreement signed in 2009.

"The New York State review process is widely regarded to be amongst the most stringent in the clinical lab industry and provides important validation for the robustness of the ColonSentry test and underlying Sentinel Principle technology," Gailina Liew, president and COO of GeneNews, said in a statement.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.